Clinical trial
A Randomized, Double-Blind, Multicenter, Placebo- and Active Comparator-Controlled Study to Evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Third Molar Tooth Extraction (STARDOM1).
NCT02982161 is registered in ClinicalTrials.gov with Mundipharma Research GmbH & Co KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Multicenter, Placebo- and Active Comparator-Controlled Study to Evaluate Efficacy and Safety of MR308 in the Treatment of Acute Pain After Third Molar Tooth Extraction (STARDOM1).
- Lead sponsor
- Mundipharma Research GmbH & Co KG
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 28, 2016
- Completion date
- January 4, 2018
- Enrollment
- 818 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.